Stock Events

Stock Events

RxSight 

$6.56
22
+$0.15+2.42% 15:02 Today

Statistics

Day High
6.58
Day Low
6.19
52W High
13.22
52W Low
4.48
Volume
3,662
Avg. Volume
-
Mkt Cap
272.64M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

11NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.38
-0.3
-0.23
-0.15
Expected EPS
-0.289674
Actual EPS
N/A

Financials

-28.96%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
134.48MRevenue
-38.94MNet Income

Analyst Ratings

7.96Average Price Target
The highest estimate is 11.00.
From 5 ratings within the last 6 months. This is not an investment recommendation.
Buy
20%
Hold
60%
Sell
20%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow RXST. It's not an investment recommendation.
Apple
7
AAPL
NVIDIA
7
NVDA
Tesla
6
TSLA
Amazon
6
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap651.25B
Johnson & Johnson, through its subsidiary Abbott Medical Optics, competes in the intraocular lens market, directly competing with RxSight's light-adjustable lens technology.
Alcon
ALC
Mkt Cap35.59B
Alcon specializes in eye care products, including intraocular lenses for cataract surgery, competing in the same space as RxSight.
Staar Surgical
STAA
Mkt Cap1.16B
STAAR Surgical Company offers implantable collamer lenses, a different approach to vision correction that competes with RxSight's offerings.
Cooper Companies
COO
Mkt Cap14.87B
The Cooper Companies, through its CooperVision segment, provides contact lenses, but its surgical segment competes in the ocular surgery market alongside RxSight.
Bausch Health Companies
BHC
Mkt Cap2.41B
Bausch Health Companies, through its Bausch + Lomb segment, offers a range of eye health products, including intraocular lenses, competing with RxSight.
Integra Lifesciences
IART
Mkt Cap1.3B
Integra LifeSciences, a provider of surgical instruments and procedures, including those for eye surgery, indirectly competes with RxSight's technology.
Novo Nordisk
NVO
Mkt Cap206.69B
Novartis, through its Alcon eye care division before its spin-off, was a direct competitor in the intraocular lens market, indicating a historical competitive landscape with RxSight.
Abbvie
ABBV
Mkt Cap468.22B
AbbVie, after acquiring Allergan, inherited a portfolio of eye care products, including intraocular lenses, positioning it as a competitor to RxSight.

About

RxSight Inc is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture, and sale of light adjustable lenses and related capital equipment.
Show more...
CEO
Aziz Mottiwala
Employees
461
Country
United States
ISIN
US78349D1072

Listings

XNAS
US
RXST
BOATS
BOATS
RXST.BOATS

0 Comments

Share your thoughts

FAQ

What is RxSight stock price today?▼
The current price of RXST is $6.56 USD — it has increased by +2.42% in the past 24 hours. Watch RxSight stock price performance more closely on the chart.
What is RxSight stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange RxSight stocks are traded under the ticker RXST.
Is RxSight stock price growing?▼
RXST stock has risen by +4.79% compared to the previous week, the month change is a +24.37% rise, over the last year RxSight has showed a -24.06% decrease.
What is RxSight market cap?▼
Today RxSight has the market capitalization of 272.64M
When is the next RxSight earnings date?▼
RxSight is going to release the next earnings report on November 11, 2026.
What were RxSight earnings last quarter?▼
RXST earnings for the last quarter are -0.29 USD per share, whereas the estimation was -0.33 USD resulting in a +11.95% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is RxSight revenue for the last year?▼
RxSight revenue for the last year amounts to 134.48M USD.
What is RxSight net income for the last year?▼
RXST net income for the last year is -38.94M USD.
How many employees does RxSight have?▼
As of August 26, 2026, the company has 461 employees.
In which sector is RxSight located?▼
RxSight operates in the Health & Wellness sector.
When did RxSight complete a stock split?▼
The last stock split for RxSight was on September 21, 2006 with a ratio of 9:1.
Where is RxSight headquartered?▼
RxSight is headquartered in ALISO VIEJO, United States.